NCT00945178 - Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

AZD1386

Single ascending and multiple (twice daily) oral doses, capsule

DRUG

Placebo for AZD1386

Single ascending and multiple (twice daily) oral doses, capsule

DRUG

Naproxen

Tablet, single oral dose, 500mg

DRUG

Placebo for Naproxen

Tablet, single oral dose

Trial Locations (1)

Research Site, Harrow